65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79723D0095
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 71% complete
IDV ceiling
$174,737,620.00
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

This Federal Supply Schedule (FSS) contract, awarded to Kowa Pharmaceuticals America Inc. (UEI: MKFCR1R78GD3) on April 1, 2023, establishes a multiple-award indefinite delivery vehicle for the supply of pharmaceuticals, drugs, and hematology-related products under GSA Schedule 61-IB. The contract carries a ceiling value of $174.7 million and extends through March 31, 2028, providing a five-year period of performance. The Veterans Integrated Service Network 12 serves as the funding federal agency, reflecting the Department of Veterans Affairs' procurement of pharmaceutical supplies for veteran healthcare services. No set-aside provisions were applied to this contract award, allowing full and open competition among qualified vendors.

The scope of supply encompasses pharmaceutical and hematology products available through the established Federal Supply Schedule framework, with specific product lines and pricing governed by the contract's price list structure. Kowa Pharmaceuticals America Inc. maintains an approved Small Business Subcontracting Plan effective for 2026, demonstrating compliance with federal subcontracting requirements. Ordering activities across Veterans Integrated Service Network 12 and potentially other federal agencies may issue task orders against this FSS contract vehicle, with individual orders subject to the negotiated pricing and terms established during the initial award period. The contract's indefinite delivery structure allows the government to procure pharmaceuticals and related hematology products as operational needs arise throughout the five-year term.

Transactions

Action Obligated Date
Add Subcontract Plan P00012 · 2026 approved small business subcontracting plan $0
Other Administrative Action P00011 · Update the alternate point for contact for contract administration $0
Supplemental Agreement for work within scope P00010 · 2026 public law pricing update $0
Other Administrative Action P00009 $0
Other Administrative Action P00008 · Administrative change modification $0
Supplemental Agreement for work within scope P00007 · Deletions $0
Add Subcontract Plan P00006 · 52.219-9 sub-contracting plan $0
Supplemental Agreement for work within scope P00005 · 2025 public law prices updates $0
Add Subcontract Plan P00004 · 2024 acceptable small business subcontracting plan $0
Supplemental Agreement for work within scope P00003 · Approved small business subcontracting plan $0
Supplemental Agreement for work within scope P00002 · 2024 public law updates $0
Supplemental Agreement for work within scope P00001 · New package size $0
Original award $0
Show all 13

Quick answers

Who was awarded contract 36F79723D0095?

36F79723D0095 was awarded to Kowa Pharmaceuticals America Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on April 1, 2023.

How much is contract 36F79723D0095 worth?

36F79723D0095's own ceiling is $174,737,620.

Who can order from contract 36F79723D0095?

36F79723D0095 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79723D0095 part of a contract vehicle?

Yes. 36F79723D0095 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79723D0095 competed?

The extent of competition for 36F79723D0095 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV